Douglas G. Cole
CIK 1486373 · last filed 2025-06-17
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$679.2K
Companies
10
Total Filings
52
Lifetime Open-Market Net
-$7.92M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| FHTX | Director | — | $4.18 | — | $0 | 5 | 2025-06-17 |
| SANA | Director | — | $2.68 | — | $0 | 6 | 2024-07-15 |
| Sigilon Therapeutics, Inc. (SGTX) Delisted | Director | — | $22.47 | — | $0 | 4 | 2023-08-11 |
| DNLI | Director | 26,564 | $21.66 | $575.4K | $0 | 8 | 2023-06-05 |
| QTRX | Director | 4,540 | $3.10 | $14.1K | $0 | 2 | 2019-01-04 |
| EDIT | Director | 3,171 | $2.50 | $7.9K | $0 | 3 | 2017-08-21 |
| AGIO | Director | 2,778 | $29.46 | $81.8K | $0 | 3 | 2016-08-11 |
| Receptos, Inc. (RCPT) Delisted | Director | — | — | — | $0 | 1 | 2013-07-19 |
| TETRAPHASE PHARMACEUTICALS INC (TTPH) Delisted | Director | 0 | — | — | $0 | 2 | 2013-05-20 |
| AVEO PHARMACEUTICALS, INC. (AVEO) Delisted | Director | 23,909 | $15.00 | $358.6K | -$7.92M | 18 | 2011-05-16 |
Recent Filings · Page 5 of 6
52 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2010-12-29 | AVEO PHARMACEUTICALS, INC. (AVEO) Delisted | Sell (S) | −23,847 | -$346.9K | EDGAR |
| 2010-12-27 | AVEO PHARMACEUTICALS, INC. (AVEO) Delisted | Sell (S) | −13,961 | -$203.2K | EDGAR |
| 2010-12-22 | AVEO PHARMACEUTICALS, INC. (AVEO) Delisted | Sell (S) | −32,300 | -$468.4K | EDGAR |
| 2010-12-21 | AVEO PHARMACEUTICALS, INC. (AVEO) Delisted | Sell (S) | −32,049 | -$451.8K | EDGAR |
| 2010-12-17 | AVEO PHARMACEUTICALS, INC. (AVEO) Delisted | Sell (S) | −18,907 | -$268.2K | EDGAR |
| 2010-12-15 | AVEO PHARMACEUTICALS, INC. (AVEO) Delisted | Sell (S) | −21,500 | -$307.4K | EDGAR |
| 2010-12-13 | AVEO PHARMACEUTICALS, INC. (AVEO) Delisted | Sell (S) | −17,500 | -$252.6K | EDGAR |
| 2010-12-09 | AVEO PHARMACEUTICALS, INC. (AVEO) Delisted | Sell (S) | −33,694 | -$503.1K | EDGAR |
| 2010-12-07 | AVEO PHARMACEUTICALS, INC. (AVEO) Delisted | Sell (S) | −35,399 | -$527.8K | EDGAR |
| 2010-12-03 | AVEO PHARMACEUTICALS, INC. (AVEO) Delisted | Sell (S) | −38,450 | -$563.1K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.